Table 3 A mitotic inhibitor, anticancer activity assessment using PASS online software
Compound no. | Antimitotic | Antineoplastic (non-small cell lung cancer) | Insulysin inhibitor | |||
|---|---|---|---|---|---|---|
Pa | Pi | Pa | Pi | Pa | Pi | |
1 | NA | NA | 0.225 | 0.054 | 0.683 | 0.011 |
2 | 0.595 | 0.005 | 0.203 | 0.076 | 0.680 | 0.011 |
3 | 0.392 | 0.014 | NA | NA | 0.675 | 0.012 |
4 | NA | NA | NA | NA | 0.751 | 0.004 |
5 | 0.216 | 0.048 | NA | NA | 0.427 | 0.076 |
6 | 0.454 | 0.010 | 0.153 | 0.153 | 0.428 | 0.076 |
7 | 0.195 | 0.060 | 0.175 | 0.114 | 0.397 | 0.089 |
8a | NA | NA | 0.197 | 0.083 | 0.874 | 0.003 |
8b | 0.145 | 0.092 | 0.241 | 0.043 | 0.832 | 0.003 |
8c | NA | NA | 0.170 | 0.122 | 0.820 | 0.003 |
8d | NA | NA | 0.160 | 0.140 | 0.829 | 0.003 |
8e | NA | NA | 0.200 | 0.079 | 0.805 | 0.003 |
8f | NA | NA | NA | NA | 0.788 | 0.004 |
9a | NA | NA | NA | NA | 0.292 | 0.145 |
9b | NA | NA | 0.298 | 0.024 | 0.239 | 0.201 |
9c | NA | NA | 0.234 | 0.048 | NA | NA |
9d | NA | NA | 0.207 | 0.071 | 0.263 | 0.173 |
9e | NA | NA | 0.238 | 0.045 | 0.226 | 0.219 |
9f | NA | NA | 0.193 | 0.088 | NA | NA |